The Latin America, Middle East and Africa Nucleic Acid Isolation and Purification Market would witness market growth of 11.8% CAGR during the forecast period (2023-2030).
The growth and evolution of this market are intrinsically linked to scientific advancements, technological innovation, and the increasing adoption of genomics and molecular biology techniques across various industries. Adopting these techniques has seen a remarkable upswing over the past few decades, driven by factors revolutionizing healthcare, research, and diagnostics. The advent of genomic medicine has revolutionized healthcare and research, making it essential to extract high-quality nucleic acids for a variety of genetic and molecular studies.
In pharmaceutical and biotechnology, nucleic acid purification is fundamental for gene expression analysis, drug target identification, and drug development. The need to isolate and purify nucleic acids from various sources, including cells and tissues, is integral to these processes. These play a critical role in forensic applications, such as DNA profiling, paternity testing, and crime scene investigations. The reliability and quality of the nucleic acid isolated can significantly impact the outcomes of these investigations.
Many countries within the LAMEA region have been focusing on improving their healthcare infrastructure by investing in hospitals, clinics, and healthcare programs to provide better services to their citizens. As per the data published in 2023 by the International Trade Administration, South Africa's healthcare system is divided into two parts: the public system, which serves approximately 85 percent of the population and accounts for roughly 48 percent of total healthcare expenditure with state support (nearly 9 percent of GDP). Therefore, the rising healthcare sector in many countries of the LAMEA region will boost the demand for this in the region.
The Brazil market dominated the LAMEA Nucleic Acid Isolation and Purification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $209.8 million by 2030. The Argentina market is showcasing a CAGR of 12.4% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 11.5% during (2023 - 2030).
Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research, and Personalized Medicine & Others. Based on Product, the market is segmented into Reagents, Kits, and Instruments. Based on Method, the market is segmented into Magnetic Beads, Column Based, Reagent Based, and Others. Based on Type, the market is segmented into Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Nucleic Acid Isolation and Purification Market is Projected to reach USD 11.5 Billion by 2030, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.
By Application
By Product
By Method
By Type
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 